Anixa Biosciences News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

08.05.24	Anixa Inks Joint Development Agreement With Cleveland Clinic To Develop Novel Cancer Vaccines (RTTNews)
14.12.23	Anixa Biosciences to Present at Biotech Showcase 2024 (PR Newswire)
07.12.23	Anixa Biosciences Announces Positive Data From Phase 1 Study Of Breast Cancer Vaccine; Stock Up (RTTNews)
07.12.23	Anixa Biosciences and Cleveland Clinic Present Positive New Data from Phase 1 Study of Breast Cancer Vaccine (PR Newswire)
06.12.23	Anixa Biosciences to Host Conference Call This Evening to Discuss Positive New Data from Ongoing Phase 1 Study of Breast Cancer Vaccine (PR Newswire)
27.11.23	Anixa Biosciences Announces European Patent on Ovarian Cancer Vaccine Technology (PR Newswire)
31.10.23	Anixa Biosciences to Present at the Ovarian Cancer Research Alliance (OCRA) Ovarian Cancer National Conference (PR Newswire)
23.10.23	Anixa Biosciences Appoints Accomplished Medical Oncologist and Biotechnology Executive, Dr. Mark A. Goldberg, to Cancer Business Advisory Board (PR Newswire)
13.10.23	Anixa Biosciences Completes Treatment of First Patient Cohort in Ovarian Cancer CAR-T Clinical Trial (PR Newswire)
03.10.23	Anixa Biosciences Announces Issuance of Additional U.S. Patent for Ovarian Cancer Vaccine Technology (PR Newswire)
19.09.23	Anixa Biosciences Establishes Cancer Business Advisory Board (PR Newswire)
31.08.23	Anixa Biosciences to Participate in September Investor Conferences (PR Newswire)
28.08.23	Anixa Biosciences Announces Treatment of Third Patient in Ovarian Cancer CAR-T Clinical Trial (PR Newswire)
14.08.23	Anixa Biosciences Announces Invited Presentation on Ovarian Cancer CAR-T Therapy at the 8th Annual CAR-TCR Summit (PR Newswire)
07.08.23	Anixa Biosciences Announces Opening of Enrollment for Keytruda® Arm in Ongoing Breast Cancer Vaccine Clinical Trial (PR Newswire)
27.07.23	Anixa Biosciences Announces Notice of Allowance of Additional Patent on Ovarian Cancer Vaccine Technology (PR Newswire)
11.07.23	Anixa Biosciences Announces Issuance of Canadian Patent for its CAR-T Cancer Therapy Technology (PR Newswire)
22.05.23	Anixa Biosciences Announces Treatment of Second Patient in its Ovarian Cancer CAR-T Clinical Trial (PR Newswire)
17.04.23	Anixa Biosciences Clarifies Poster Presentation on Company Website (PR Newswire)
17.04.23	Anixa Biosciences and Cleveland Clinic Present Positive Data for Phase 1 Study of Breast Cancer Vaccine (PR Newswire)
27.03.23	Anixa Biosciences Announces Presentation on Breast Cancer Vaccine Trial at the 2023 AACR Annual Meeting (PR Newswire)
13.03.23	Anixa Biosciences Reassures Shareholders It Has No Accounts at Silicon Valley Bank (PR Newswire)
02.03.23	Anixa Biosciences to Provide Corporate Update at its 2023 Annual Meeting of Stockholders (PR Newswire)
27.02.23	Anixa Biosciences Announces Notice of Allowance of Additional Key Patent on Breast Cancer Vaccine Technology (PR Newswire)
21.02.23	Anixa Biosciences Announces Formation of Breast Cancer Clinical Advisory Board (PR Newswire)
19.12.22	Anixa Biosciences to Present at Biotech Showcase 2023 (PR Newswire)
08.12.22	Anixa Biosciences Announces Maximum Tolerated Dose Reached in Trial of Preventative Breast Cancer Vaccine (PR Newswire)
08.11.22	Anixa Biosciences Announces Presentation on Breast Cancer Vaccine Trial at the 2022 San Antonio Breast Cancer Symposium (PR Newswire)
31.10.22	Dr. Jose Conejo-Garcia, Invited to Present Keynote Address at Duke Cancer Institute, will Discuss Anixa Biosciences' Ovarian Cancer CAR-T Therapy (PR Newswire)
26.10.22	Anixa Biosciences Announces Commencement of Phase 1b Trial of its Breast Cancer Vaccine at Cleveland Clinic (PR Newswire)
10.10.22	Anixa Biosciences Announces Presentation on Ovarian Cancer CAR-T Therapy Trial at the Society for Immunotherapy of Cancer (SITC) Annual Meeting (PR Newswire)
12.09.22	Anixa Biosciences' Ovarian Cancer CAR-T Therapy to be Presented at the Rivkin Center & American Association of Cancer Research (AACR) 14th Biennial Ovarian Cancer Research Symposium (PR Newswire)
31.08.22	Anixa Biosciences to Present at the H.C. Wainwright 24th Annual Global Investment Conference (PR Newswire)
15.08.22	Anixa Biosciences Announces Treatment of First Patient in its Ovarian Cancer CAR-T Clinical Trial (PR Newswire)
21.07.22	Anixa Biosciences Announces Notice of Allowance of Additional Patent on Breast Cancer Vaccine Technology (PR Newswire)
21.06.22	Anixa Publishes Scientific Paper On Preventative Ovarian Cancer Technology (RTTNews)
21.06.22	Anixa Biosciences Announces Publication of Peer-Reviewed Journal Article in Clinical and Experimental Vaccine Research Highlighting Ovarian Cancer Vaccine Technology (PR Newswire)
13.06.22	Pre-market Movers: BLUE, MSTR, VALN, RDBX, DBVT… (RTTNews)
05.05.22	Anixa Biosciences to Present at the 2022 H.C. Wainwright Global Investment Conference (PR Newswire)
28.04.22	Anixa Biosciences Announces Presentation on Breast Cancer Vaccine Trial at the American Society of Clinical Oncology (ASCO) Annual Meeting (PR Newswire)
06.04.22	Anixa Biosciences' Ovarian Cancer CAR-T Therapy to be Discussed at The 4th International Workshop on CAR-T 2022 (PR Newswire)
30.03.22	Anixa Biosciences Announces the Initiation of its Ovarian Cancer CAR-T Phase 1 Trial at Moffitt Cancer Center (PR Newswire)
17.03.22	Anixa Biosciences to Participate in the 2022 Virtual Growth Conference Hosted by M-Vest, a Division of Maxim Group LLC (PR Newswire)
07.03.22	Pre-market Movers: HUSA, BBBY, NINE, IMPP, MXC… (RTTNews)
25.01.22	Anixa Biosciences Announces Japanese Patent on Ovarian Cancer Vaccine (PR Newswire)
24.01.22	Anixa Biosciences and MolGenie Announce Early Potency Analysis of SARS-CoV-2 Protease Inhibitor (PR Newswire)
16.12.21	Anixa Biosciences to Participate in Upcoming January Investor Conferences: LifeSci Partners Annual Corporate Access Event and H.C. Wainwright BioConnect Conference (PR Newswire)
07.12.21	Anixa : COVID-19 Compounds Expected To Be Effective Against Omicron And Delta Variants (RTTNews)
07.12.21	Anixa Biosciences and MolGenie Announce that their COVID-19 Compounds are Expected to be Effective Against the Omicron Variant (PR Newswire)
26.10.21	Anixa Biosciences Announces Patient Dosing of its Investigational Vaccine Candidate in a First-of-its-Kind Preventative Breast Cancer Vaccine Study (PR Newswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Alcon	77.84	2.10 %	K V
CieFinRichemont	122.45	1.07 %	K V
Lonza Grp	531.40	0.91 %	K V
Zurich Insur Gr	552.40	0.07 %	K V
Logitech Intl	72.22	0.03 %	K V
Swiss Life Hldg	718.20	-0.99 %	K V
ABB	49.42	-1.08 %	K V
Sika	228.70	-1.08 %	K V
Holcim	88.34	-1.60 %	K V
UBS Group	27.65	-2.47 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Anixa Biosciences Inc Registered Shs

Aktien Top/Flop

Meistgelesene Nachrichten